ChineseInvestors.com’s (OTCQB: CIIX) first retail store is expected to open in June in San Gabriel, California. It will be among the first stores to sell “OptHemp,” a premium health product line launched by CIIX’s wholly owned subsidiary chinesehempoil.com, Inc. The “OptHemp” line will include OptHemp Ultra Premium Hemp Oil, the company’s first private label product.
CIIX offers educational tools and consulting services for Chinese investors. Recently, it has been pursuing its niche in the expanding cannabis (CBD) market. The company’s goal is to become a leading Chinese publicly traded company in the nutritional industry. CIIX’s retail store in California will primarily sell hemp oil-based products, which it will market via a new website, mobile application, and online distribution program to penetrate the rapidly growing hemp-based CBD market.
“I am very pleased to announce the launch of our first premium OptHemp product,” Warren Wang, founder and CEO of CIIX, stated in a recent news release. “Hemp oil is believed to have positive balancing effects on the mind and body of persons using them.”
The formula for OptHemp has been optimized to manage inflammation and pain relief. The OptHemp premium line is GMO-free, reinforcing the product’s purity to users. It is grown in organic farms in Colorado using a CO2 extraction technology.
“We believe that the desire for better quality of life in the Chinese community, coupled with the fact that the aging population continues to grow, will lead to continued growth in the alternative health sector and increased demand for natural hemp-based health products,” Wang said. “CIIX is confident that its OptHemp product line will lay a solid foundation for the Company’s entrance into the legal hemp industry and the alternative health sector.”
In the future, CIIX will focus on the distribution and R&D into the CBD market. Its products can be used for patients with epilepsy, Alzheimer’s disease, and cirrhosis of the liver. In China, use of marijuana is forbidden, though hemp-based CBDs are legal, creating a target market of approximately 2 billion consumers.
For more information, visit the company’s website at www.ChineseInvestors.com
About CBDWire
CBDWire (CBDW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
Please see full disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, CO
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
